AXFLUNA
Live / Registered — Registered (as of 03 Feb 2026)
What this means for you
Registered since 03 Feb 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98891669
- Registration number
- 8123335
- Mark type
- Stylized text
- Filed
- 09 Dec 2024
- Published for opposition
- 16 Dec 2025
- Registered
- 03 Feb 2026
- Attorney of record
- Elizabeth K. Rucki
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders
Owner
- GlaxoSmithKline Biologicals SA, Rixensart, BE
- GlaxoSmithKline Biologicals SA, Rixensart, BE
- GlaxoSmithKline Biologicals SA, Rixensart, BE
Prosecution history
- 03 Feb 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Feb 2026 — REGISTERED-PRINCIPAL REGISTER
- 16 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Dec 2025 — PUBLISHED FOR OPPOSITION
- 10 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 17 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 17 Oct 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 14 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 14 Oct 2025 — NON-FINAL ACTION E-MAILED
- 14 Oct 2025 — NON-FINAL ACTION WRITTEN
- 16 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 16 Sept 2025 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED